 | • レポートコード：QFJ1-6073 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、女性用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン不妊症、閉経後骨粗しょう症、子宮内膜症、避妊薬、更年期障害、多嚢胞性卵巣症候群、その他）、用途別市場規模（処方薬、一般用医薬品）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・女性用医薬品の市場動向 ・企業の競争状況、市場シェア ・女性用医薬品の種類別市場規模と予測2016-2027（ホルモン不妊症、閉経後骨粗しょう症、子宮内膜症、避妊薬、更年期障害、多嚢胞性卵巣症候群、その他） ・女性用医薬品の用途別市場規模と予測2016-2027（処方薬、一般用医薬品） ・女性用医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・女性用医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・女性用医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・女性用医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・女性用医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer AG、Allergan、Merck & Co、Pfizer Inc.、Amgen、Agile Therapeutics、Ferring Pharmaceuticals、Mylan N.V.、Lupin、Blairex Laboratories、Apothecus Pharmaceutical） ・結論 |
Drugs specialized for women’s health.
Market Analysis and Insights: Global Women’s Health Care Drugs Market
The global Women’s Health Care Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Women’s Health Care Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Women’s Health Care Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Women’s Health Care Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Women’s Health Care Drugs market.
Global Women’s Health Care Drugs Scope and Market Size
Women’s Health Care Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Women’s Health Care Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Hormonal Infertility
Postmenopausal Osteoporosis
Endometriosis
Contraceptives
Menopause
Polycystic Ovary Syndrome
Others
Segment by Application
Prescription Drugs
Non-prescription Drugs
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bayer AG
Allergan
Merck & Co
Pfizer Inc.
Amgen
Agile Therapeutics
Ferring Pharmaceuticals
Mylan N.V.
Lupin
Blairex Laboratories
Apothecus Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Women’s Health Care Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hormonal Infertility
1.2.3 Postmenopausal Osteoporosis
1.2.4 Endometriosis
1.2.5 Contraceptives
1.2.6 Menopause
1.2.7 Polycystic Ovary Syndrome
1.2.8 Others
1.3 Market by Application
1.3.1 Global Women’s Health Care Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Prescription Drugs
1.3.3 Non-prescription Drugs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Women’s Health Care Drugs Market Perspective (2016-2027)
2.2 Women’s Health Care Drugs Growth Trends by Regions
2.2.1 Women’s Health Care Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Women’s Health Care Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Women’s Health Care Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Women’s Health Care Drugs Industry Dynamic
2.3.1 Women’s Health Care Drugs Market Trends
2.3.2 Women’s Health Care Drugs Market Drivers
2.3.3 Women’s Health Care Drugs Market Challenges
2.3.4 Women’s Health Care Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Women’s Health Care Drugs Players by Revenue
3.1.1 Global Top Women’s Health Care Drugs Players by Revenue (2016-2021)
3.1.2 Global Women’s Health Care Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Women’s Health Care Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Women’s Health Care Drugs Revenue
3.4 Global Women’s Health Care Drugs Market Concentration Ratio
3.4.1 Global Women’s Health Care Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Women’s Health Care Drugs Revenue in 2020
3.5 Women’s Health Care Drugs Key Players Head office and Area Served
3.6 Key Players Women’s Health Care Drugs Product Solution and Service
3.7 Date of Enter into Women’s Health Care Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Women’s Health Care Drugs Breakdown Data by Type
4.1 Global Women’s Health Care Drugs Historic Market Size by Type (2016-2021)
4.2 Global Women’s Health Care Drugs Forecasted Market Size by Type (2022-2027)
5 Women’s Health Care Drugs Breakdown Data by Application
5.1 Global Women’s Health Care Drugs Historic Market Size by Application (2016-2021)
5.2 Global Women’s Health Care Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Women’s Health Care Drugs Market Size (2016-2027)
6.2 North America Women’s Health Care Drugs Market Size by Type
6.2.1 North America Women’s Health Care Drugs Market Size by Type (2016-2021)
6.2.2 North America Women’s Health Care Drugs Market Size by Type (2022-2027)
6.2.3 North America Women’s Health Care Drugs Market Size by Type (2016-2027)
6.3 North America Women’s Health Care Drugs Market Size by Application
6.3.1 North America Women’s Health Care Drugs Market Size by Application (2016-2021)
6.3.2 North America Women’s Health Care Drugs Market Size by Application (2022-2027)
6.3.3 North America Women’s Health Care Drugs Market Size by Application (2016-2027)
6.4 North America Women’s Health Care Drugs Market Size by Country
6.4.1 North America Women’s Health Care Drugs Market Size by Country (2016-2021)
6.4.2 North America Women’s Health Care Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Women’s Health Care Drugs Market Size (2016-2027)
7.2 Europe Women’s Health Care Drugs Market Size by Type
7.2.1 Europe Women’s Health Care Drugs Market Size by Type (2016-2021)
7.2.2 Europe Women’s Health Care Drugs Market Size by Type (2022-2027)
7.2.3 Europe Women’s Health Care Drugs Market Size by Type (2016-2027)
7.3 Europe Women’s Health Care Drugs Market Size by Application
7.3.1 Europe Women’s Health Care Drugs Market Size by Application (2016-2021)
7.3.2 Europe Women’s Health Care Drugs Market Size by Application (2022-2027)
7.3.3 Europe Women’s Health Care Drugs Market Size by Application (2016-2027)
7.4 Europe Women’s Health Care Drugs Market Size by Country
7.4.1 Europe Women’s Health Care Drugs Market Size by Country (2016-2021)
7.4.2 Europe Women’s Health Care Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Women’s Health Care Drugs Market Size (2016-2027)
8.2 Asia-Pacific Women’s Health Care Drugs Market Size by Type
8.2.1 Asia-Pacific Women’s Health Care Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Women’s Health Care Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Women’s Health Care Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Women’s Health Care Drugs Market Size by Application
8.3.1 Asia-Pacific Women’s Health Care Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Women’s Health Care Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Women’s Health Care Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Women’s Health Care Drugs Market Size by Region
8.4.1 Asia-Pacific Women’s Health Care Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Women’s Health Care Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Women’s Health Care Drugs Market Size (2016-2027)
9.2 Latin America Women’s Health Care Drugs Market Size by Type
9.2.1 Latin America Women’s Health Care Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Women’s Health Care Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Women’s Health Care Drugs Market Size by Type (2016-2027)
9.3 Latin America Women’s Health Care Drugs Market Size by Application
9.3.1 Latin America Women’s Health Care Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Women’s Health Care Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Women’s Health Care Drugs Market Size by Application (2016-2027)
9.4 Latin America Women’s Health Care Drugs Market Size by Country
9.4.1 Latin America Women’s Health Care Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Women’s Health Care Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Women’s Health Care Drugs Market Size (2016-2027)
10.2 Middle East & Africa Women’s Health Care Drugs Market Size by Type
10.2.1 Middle East & Africa Women’s Health Care Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Women’s Health Care Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Women’s Health Care Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Women’s Health Care Drugs Market Size by Application
10.3.1 Middle East & Africa Women’s Health Care Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Women’s Health Care Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Women’s Health Care Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Women’s Health Care Drugs Market Size by Country
10.4.1 Middle East & Africa Women’s Health Care Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Women’s Health Care Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Women’s Health Care Drugs Introduction
11.1.4 Bayer AG Revenue in Women’s Health Care Drugs Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Women’s Health Care Drugs Introduction
11.2.4 Allergan Revenue in Women’s Health Care Drugs Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Merck & Co
11.3.1 Merck & Co Company Details
11.3.2 Merck & Co Business Overview
11.3.3 Merck & Co Women’s Health Care Drugs Introduction
11.3.4 Merck & Co Revenue in Women’s Health Care Drugs Business (2016-2021)
11.3.5 Merck & Co Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Details
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Women’s Health Care Drugs Introduction
11.4.4 Pfizer Inc. Revenue in Women’s Health Care Drugs Business (2016-2021)
11.4.5 Pfizer Inc. Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Women’s Health Care Drugs Introduction
11.5.4 Amgen Revenue in Women’s Health Care Drugs Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Agile Therapeutics
11.6.1 Agile Therapeutics Company Details
11.6.2 Agile Therapeutics Business Overview
11.6.3 Agile Therapeutics Women’s Health Care Drugs Introduction
11.6.4 Agile Therapeutics Revenue in Women’s Health Care Drugs Business (2016-2021)
11.6.5 Agile Therapeutics Recent Development
11.7 Ferring Pharmaceuticals
11.7.1 Ferring Pharmaceuticals Company Details
11.7.2 Ferring Pharmaceuticals Business Overview
11.7.3 Ferring Pharmaceuticals Women’s Health Care Drugs Introduction
11.7.4 Ferring Pharmaceuticals Revenue in Women’s Health Care Drugs Business (2016-2021)
11.7.5 Ferring Pharmaceuticals Recent Development
11.8 Mylan N.V.
11.8.1 Mylan N.V. Company Details
11.8.2 Mylan N.V. Business Overview
11.8.3 Mylan N.V. Women’s Health Care Drugs Introduction
11.8.4 Mylan N.V. Revenue in Women’s Health Care Drugs Business (2016-2021)
11.8.5 Mylan N.V. Recent Development
11.9 Lupin
11.9.1 Lupin Company Details
11.9.2 Lupin Business Overview
11.9.3 Lupin Women’s Health Care Drugs Introduction
11.9.4 Lupin Revenue in Women’s Health Care Drugs Business (2016-2021)
11.9.5 Lupin Recent Development
11.10 Blairex Laboratories
11.10.1 Blairex Laboratories Company Details
11.10.2 Blairex Laboratories Business Overview
11.10.3 Blairex Laboratories Women’s Health Care Drugs Introduction
11.10.4 Blairex Laboratories Revenue in Women’s Health Care Drugs Business (2016-2021)
11.10.5 Blairex Laboratories Recent Development
11.11 Apothecus Pharmaceutical
11.11.1 Apothecus Pharmaceutical Company Details
11.11.2 Apothecus Pharmaceutical Business Overview
11.11.3 Apothecus Pharmaceutical Women’s Health Care Drugs Introduction
11.11.4 Apothecus Pharmaceutical Revenue in Women’s Health Care Drugs Business (2016-2021)
11.11.5 Apothecus Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Women's Health Care Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hormonal Infertility
Table 3. Key Players of Postmenopausal Osteoporosis
Table 4. Key Players of Endometriosis
Table 5. Key Players of Contraceptives
Table 6. Key Players of Menopause
Table 7. Key Players of Polycystic Ovary Syndrome
Table 8. Key Players of Others
Table 9. Global Women's Health Care Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Women's Health Care Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Women's Health Care Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Women's Health Care Drugs Market Share by Regions (2016-2021)
Table 13. Global Women's Health Care Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Women's Health Care Drugs Market Share by Regions (2022-2027)
Table 15. Women's Health Care Drugs Market Trends
Table 16. Women's Health Care Drugs Market Drivers
Table 17. Women's Health Care Drugs Market Challenges
Table 18. Women's Health Care Drugs Market Restraints
Table 19. Global Women's Health Care Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Women's Health Care Drugs Market Share by Players (2016-2021)
Table 21. Global Top Women's Health Care Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women's Health Care Drugs as of 2020)
Table 22. Ranking of Global Top Women's Health Care Drugs Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Women's Health Care Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Women's Health Care Drugs Product Solution and Service
Table 26. Date of Enter into Women's Health Care Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Women's Health Care Drugs Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Women's Health Care Drugs Revenue Market Share by Type (2016-2021)
Table 30. Global Women's Health Care Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Women's Health Care Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Women's Health Care Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Women's Health Care Drugs Revenue Market Share by Application (2016-2021)
Table 34. Global Women's Health Care Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Women's Health Care Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Women's Health Care Drugs Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Women's Health Care Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Women's Health Care Drugs Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Women's Health Care Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Women's Health Care Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Women's Health Care Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Women's Health Care Drugs Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Women's Health Care Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Women's Health Care Drugs Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Women's Health Care Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Women's Health Care Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Women's Health Care Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Women's Health Care Drugs Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Women's Health Care Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Women's Health Care Drugs Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Women's Health Care Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Women's Health Care Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Women's Health Care Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Women's Health Care Drugs Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Women's Health Care Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Women's Health Care Drugs Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Women's Health Care Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Women's Health Care Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Women's Health Care Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Women's Health Care Drugs Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Women's Health Care Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Women's Health Care Drugs Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Women's Health Care Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Women's Health Care Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Women's Health Care Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 66. Bayer AG Company Details
Table 67. Bayer AG Business Overview
Table 68. Bayer AG Women's Health Care Drugs Product
Table 69. Bayer AG Revenue in Women's Health Care Drugs Business (2016-2021) & (US$ Million)
Table 70. Bayer AG Recent Development
Table 71. Allergan Company Details
Table 72. Allergan Business Overview
Table 73. Allergan Women's Health Care Drugs Product
Table 74. Allergan Revenue in Women's Health Care Drugs Business (2016-2021) & (US$ Million)
Table 75. Allergan Recent Development
Table 76. Merck & Co Company Details
Table 77. Merck & Co Business Overview
Table 78. Merck & Co Women's Health Care Drugs Product
Table 79. Merck & Co Revenue in Women's Health Care Drugs Business (2016-2021) & (US$ Million)
Table 80. Merck & Co Recent Development
Table 81. Pfizer Inc. Company Details
Table 82. Pfizer Inc. Business Overview
Table 83. Pfizer Inc. Women's Health Care Drugs Product
Table 84. Pfizer Inc. Revenue in Women's Health Care Drugs Business (2016-2021) & (US$ Million)
Table 85. Pfizer Inc. Recent Development
Table 86. Amgen Company Details
Table 87. Amgen Business Overview
Table 88. Amgen Women's Health Care Drugs Product
Table 89. Amgen Revenue in Women's Health Care Drugs Business (2016-2021) & (US$ Million)
Table 90. Amgen Recent Development
Table 91. Agile Therapeutics Company Details
Table 92. Agile Therapeutics Business Overview
Table 93. Agile Therapeutics Women's Health Care Drugs Product
Table 94. Agile Therapeutics Revenue in Women's Health Care Drugs Business (2016-2021) & (US$ Million)
Table 95. Agile Therapeutics Recent Development
Table 96. Ferring Pharmaceuticals Company Details
Table 97. Ferring Pharmaceuticals Business Overview
Table 98. Ferring Pharmaceuticals Women's Health Care Drugs Product
Table 99. Ferring Pharmaceuticals Revenue in Women's Health Care Drugs Business (2016-2021) & (US$ Million)
Table 100. Ferring Pharmaceuticals Recent Development
Table 101. Mylan N.V. Company Details
Table 102. Mylan N.V. Business Overview
Table 103. Mylan N.V. Revenue in Women's Health Care Drugs Business (2016-2021) & (US$ Million)
Table 104. Mylan N.V. Recent Development
Table 105. Lupin Company Details
Table 106. Lupin Business Overview
Table 107. Lupin Women's Health Care Drugs Product
Table 108. Lupin Revenue in Women's Health Care Drugs Business (2016-2021) & (US$ Million)
Table 109. Lupin Recent Development
Table 110. Blairex Laboratories Company Details
Table 111. Blairex Laboratories Business Overview
Table 112. Blairex Laboratories Women's Health Care Drugs Product
Table 113. Blairex Laboratories Revenue in Women's Health Care Drugs Business (2016-2021) & (US$ Million)
Table 114. Blairex Laboratories Recent Development
Table 115. Apothecus Pharmaceutical Company Details
Table 116. Apothecus Pharmaceutical Business Overview
Table 117. Apothecus Pharmaceutical Women's Health Care Drugs Product
Table 118. Apothecus Pharmaceutical Revenue in Women's Health Care Drugs Business (2016-2021) & (US$ Million)
Table 119. Apothecus Pharmaceutical Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Women's Health Care Drugs Market Share by Type: 2020 VS 2027
Figure 2. Hormonal Infertility Features
Figure 3. Postmenopausal Osteoporosis Features
Figure 4. Endometriosis Features
Figure 5. Contraceptives Features
Figure 6. Menopause Features
Figure 7. Polycystic Ovary Syndrome Features
Figure 8. Others Features
Figure 9. Global Women's Health Care Drugs Market Share by Application: 2020 VS 2027
Figure 10. Prescription Drugs Case Studies
Figure 11. Non-prescription Drugs Case Studies
Figure 12. Women's Health Care Drugs Report Years Considered
Figure 13. Global Women's Health Care Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Women's Health Care Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Women's Health Care Drugs Market Share by Regions: 2020 VS 2027
Figure 16. Global Women's Health Care Drugs Market Share by Regions (2022-2027)
Figure 17. Global Women's Health Care Drugs Market Share by Players in 2020
Figure 18. Global Top Women's Health Care Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women's Health Care Drugs as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Women's Health Care Drugs Revenue in 2020
Figure 20. Global Women's Health Care Drugs Revenue Market Share by Type (2016-2021)
Figure 21. Global Women's Health Care Drugs Revenue Market Share by Type (2022-2027)
Figure 22. North America Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Women's Health Care Drugs Market Share by Type (2016-2027)
Figure 24. North America Women's Health Care Drugs Market Share by Application (2016-2027)
Figure 25. North America Women's Health Care Drugs Market Share by Country (2016-2027)
Figure 26. United States Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Women's Health Care Drugs Market Share by Type (2016-2027)
Figure 30. Europe Women's Health Care Drugs Market Share by Application (2016-2027)
Figure 31. Europe Women's Health Care Drugs Market Share by Country (2016-2027)
Figure 32. Germany Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Women's Health Care Drugs Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Women's Health Care Drugs Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Women's Health Care Drugs Market Share by Region (2016-2027)
Figure 42. China Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Women's Health Care Drugs Market Share by Type (2016-2027)
Figure 50. Latin America Women's Health Care Drugs Market Share by Application (2016-2027)
Figure 51. Latin America Women's Health Care Drugs Market Share by Country (2016-2027)
Figure 52. Mexico Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Women's Health Care Drugs Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Women's Health Care Drugs Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Women's Health Care Drugs Market Share by Country (2016-2027)
Figure 58. Turkey Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Women's Health Care Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Bayer AG Revenue Growth Rate in Women's Health Care Drugs Business (2016-2021)
Figure 62. Allergan Revenue Growth Rate in Women's Health Care Drugs Business (2016-2021)
Figure 63. Merck & Co Revenue Growth Rate in Women's Health Care Drugs Business (2016-2021)
Figure 64. Pfizer Inc. Revenue Growth Rate in Women's Health Care Drugs Business (2016-2021)
Figure 65. Amgen Revenue Growth Rate in Women's Health Care Drugs Business (2016-2021)
Figure 66. Agile Therapeutics Revenue Growth Rate in Women's Health Care Drugs Business (2016-2021)
Figure 67. Ferring Pharmaceuticals Revenue Growth Rate in Women's Health Care Drugs Business (2016-2021)
Figure 68. Mylan N.V. Revenue Growth Rate in Women's Health Care Drugs Business (2016-2021)
Figure 69. Lupin Revenue Growth Rate in Women's Health Care Drugs Business (2016-2021)
Figure 70. Blairex Laboratories Revenue Growth Rate in Women's Health Care Drugs Business (2016-2021)
Figure 71. Apothecus Pharmaceutical Revenue Growth Rate in Women's Health Care Drugs Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
多嚢胞性卵巣症候群（PCOS）治療薬のグローバル市場調査 2019年 The global Polycystic Ovary Syndrome (PCOS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polycystic Ovary Syndrome (PCOS) Drugs volume and value at global level, regional level and company …- 多嚢胞性卵巣症候群（PCOS）治療薬のグローバル市場調査 2019年 The global Polycystic Ovary Syndrome (PCOS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polycystic Ovary Syndrome (PCOS) Drugs volume and value at global level, regional level and company …
- 世界の過敏性腸症候群（IBS）処方薬市場規模・現状・予測（2021年-2027年） Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. Market Analysis and Insights: Global Rx Irritable Bowel Syndrome (IBS) Drugs Market The global Rx Irritable Bowel Syndrome (IBS…
- 世界の女性用不妊治療薬市場規模・現状・予測（2021年-2027年） Female infertility refers to infertility in women. It affects an estimated 48 million women,with the highest prevalence of infertility affecting people in South Asia, Sub-Saharan Africa, North Africa/Middle East, and Central/Eastern Europe and Central Asia. The adverse effects and high cost of non-t…
- 世界の犬用処方薬産業調査2019-2025 Dog prescription drug is a kind of animal prescription. Animal prescription drug is a prescription drug used to prevent, treat, diagnose, or purposefully regulate an animal's physiology. Animal prescription drugs mainly include: serum products, vaccines, diagnostic products, micro-ecological product…